NCT05477602Completed
The Automated Calculation of AF Cycle Length and Complexity Using a Novel EP Recording System
The Automated Calculation of AF Cycle Length and Complexity Using a Novel EP Recording System (The CathVision ECGenius System)
Source: ClinicalTrials.gov · Last updated 30 Jan 2026
Brief summary (registry, in English)
Collect electrophysiological data during atrial fibrillation (AF) ablation procedures to assess the performance of a Signal Complexity Visualization algorithm designed to be integrated into the CathVision ECGenius® System.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 21 (actual)
- First submitted
- 25 Jul 2022
- Start date
- 16 Jan 2023
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- CathVision ApS
- Diseases
- Atrial fibrillation
- NCT number
- NCT05477602
What you commit to
- Study type: Observational
- Participants enrolled: 21
- From 16 Jan 2023 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current participation in another investigational drug or device study that interferes with this study.
Other illness
- Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements, or impact the scientific soundness of the clinical investigation results.
Other
- Life expectancy less than 12 month, in the opinion of the Investigator.
- Subjects who, in the opinion of the investigator, are not candidates for this study.
- Subjects who, in the opinion of the investigator, are considered part of any vulnerable population.
Who the study is looking for
- Subjects undergoing RF ablation indicated by the investigator for the treatment of persistent atrial fibrillation.
- Male or non-pregnant female aged ≥ 21 years.
- Able and willing to provide written informed consent prior to any clinical investigation related procedure.
Age in the registry: 21 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| OLV Aalst Coordinator of this site? Confirm its status | Aalst | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.